Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Oncotarget|December 22, 2017
Advances in the understanding and management of T-cell prolymphocytic leukemiaKamel Laribi, Pierre Lemaire, Jeremy Sandrini, et al.
Annales De Biologie Clinique|November 11, 2015
[Blastic plasmacytoid dendritic cell neoplasm: two case reports]Mohamed Kaabar, Pierre Lemaire, Kamel Laribi, et al.
Annales De Biologie Clinique|August 7, 2018
[Lymphoplasmacytic lymphoma or multiple myeloma: immunoglobulins may lead to misdiagnosis]Jérôme Debus, Pierre Lemaire, Mustafa Alani, et al.
Cancer Medicine|April 18, 2019
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with AzacitidineKamel Laribi, Delphine Bolle, Mustafa Alani, et al.
Annales De Biologie Clinique|August 7, 2018
[Shwachman-Diamond syndrome: a case report]Mohamed Kaabar, Pierre Lemaire, Vincent Cussac, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted TherapiesKamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Annales De Biologie Clinique|June 16, 2018
[Chronic lymphocytic leukemia with t(14 ;18) and trisomy 12: a case report]Maïlys Le Guyader, Marie Coude, Kamel Laribi, et al.
Cancer Management and Research|April 10, 2019
Management of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): focus on chlormethine gelDaphné Denis, Nathalie Beneton, Kamel Laribi, et al.
Hematological Oncology|July 23, 2016
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphomaKamel Laribi, Adrien Tempescul, Habib Ghnaya, et al.
Oncology|January 20, 2022
Retacrit®, Biosimilar of Epoetin Alfa, in Chemotherapy-Induced Anemia in Routine Practice: Impact of Iron SupplementationKamel Laribi, Dominique Spaeth, Florian Scotte, et al.
Pageof 16